MedPath

Mental Activity During (TMS) Therapy for Depression

Not Applicable
Completed
Conditions
Cognitive Impairment
Registration Number
NCT03701932
Lead Sponsor
Augusta University
Brief Summary

The purpose of the study is to assess the effects of different types of mental activity performed while receiving transcranial magnetic stimulation (TMS) for the treatment of major depressive disorder. Our primary aim for this study is to assess the feasibility of combining TMS and computer based cognitive exercise in patients with major depressive disorder who may also have some degree of cognitive dysfunction, and to formally measure changes in mood and cognition over the course of the study.

Detailed Description

Patients will receive TMS treatment daily for 6 weeks as part of their standard care. They will complete clinical assessments and participate in cognitive retraining through completion of 15 hours of Lumosity gaming cognitive exercises while simultaneously receiving active TMS stimulation. Those participants in the control group will complete 15 hours of computer gaming activity during the administration of active stimulation. Computer games in the control group exercises are elected by the patient from a library of intellectually and motivationally engaging games drawn from several gaming software compilations that includes Play 101 Games and Hoyle Puzzle and Board Games.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
11
Inclusion Criteria
  • • Subject has a diagnosis of depression

    • Subject has been approved and scheduled to receive TMS at Augusta University
    • Subject does not have a major neurocognitive impairment or an alcohol or substance abuse disorder, and can see images on a computer monitor.
Exclusion Criteria

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
The University of Pennsylvania Computerized Neuropsychological Testing Battery (Penn CNP)Change from baseline at six weeks

Administers computerized neuropsychological tests for research studies

Secondary Outcome Measures
NameTimeMethod
Hamilton Depression Rating Scale 17 itemChange from baseline at six weeks

Clinician Rating of Depressive Symptoms

The Lumosity® Brain Performance Test (BPT)Change from baseline at six weeks

Online neuropsychological battery of assessments measuring training-related changes in Cognitive Performance

Inventory of Depressive Symptoms- Self ReportChange from baseline at six weeks

Patient rating of depressive symptom severity

Trial Locations

Locations (1)

Augusta University

🇺🇸

Augusta, Georgia, United States

Augusta University
🇺🇸Augusta, Georgia, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.